The emerging role of SHANK genes in neuropsychiatric disorders

Developmental Neurobiology

Volumn 74, Issue 2, 2014, Pages 113-122

  Guilmatre, Audrey ^a,b   Huguet, Guillaume ^a,b   Delorme, Richard ^a,b,c   Bourgeron, Thomas ^a,b  

^a INSTITUT PASTEUR   (France)

^b INSTITUT PASTEUR   (France)

^c HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

Neuropsychiatric disorders; Phelan McDermid syndrome; SHANK

Indexed keywords

SCAFFOLD PROTEIN; SHANK 1 PROTEIN; SHANK 2 PROTEIN; SHANK 3 PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANXIETY; ARTICLE; ASPERGER SYNDROME; AUTISM; BIPOLAR DISORDER; DISEASE SEVERITY; GENE; GENE MUTATION; HUMAN; INTELLECTUAL IMPAIRMENT; LANGUAGE DISABILITY; MENTAL DISEASE; NEUROPATHOLOGY; NONHUMAN; PHELAN MCDERMID SYNDROME; POSTSYNAPTIC DENSITY; PRIORITY JOURNAL; SCHIZOPHRENIA; SEX DIFFERENCE; SOCIAL BEHAVIOR; SYNAPSE;

NEUROPSYCHIATRIC DISORDERS; PHELAN-MCDERMID SYNDROME; SHANK;

ALZHEIMER DISEASE; ANIMALS; BIPOLAR DISORDER; CHILD DEVELOPMENT DISORDERS, PERVASIVE; CHROMOSOME DELETION; CHROMOSOME DISORDERS; CHROMOSOMES, HUMAN, PAIR 22; HUMANS; MENTAL DISORDERS; MUTATION; NERVE TISSUE PROTEINS; SCHIZOPHRENIA;

EID: 84891902104     PISSN: 19328451     EISSN: 10974695     Source Type: Journal    
DOI: 10.1002/dneu.22128     Document Type: Article

References (62)

1. Anderlid BM, Schoumans J, Anneren G, Tapia-Paez I, Dumanski J, Blennow E, Nordenskjold M. 2002. FISH-mapping of a 100-kb terminal 22q13 deletion. Hum Genet 110:439-443.
2. Berkel S, Marshall CR, Weiss B, Howe J, Roeth R, Moog U, Endris V, et al. 2010. Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation. Nat Genet 42:489-491.
3. Boccuto L, Lauri M, Sarasua SM, Skinner CD, Buccella D, Dwivedi A, Orteschi D, et al. 2013. Prevalence of SHANK3 variants in patients with different subtypes of autism spectrum disorders. Eur J Hum Genet 21:310-316.
4. Bockers TM, Segger-Junius M, Iglauer P, Bockmann J, Gundelfinger ED, Kreutz MR, Richter D, et al. 2004. Differential expression and dendritic transcript localization of Shank family members: Identification of a dendritic targeting element in the 3′ untranslated region of Shank1 mRNA. Mol Cell Neurosci 26:182-190.
5. Boeckers TM, Bockmann J, Kreutz MR, Gundelfinger ED. 2002. ProSAP/Shank proteins-A family of higher order organizing molecules of the postsynaptic density with an emerging role in human neurological disease. J Neurochem 81:903-910.
6. Boeckers TM, Winter C, Smalla KH, Kreutz MR, Bockmann J, Seidenbecher C, Garner CC, et al. 1999. Proline-rich synapse-associated proteins ProSAP1 and ProSAP2 interact with synaptic proteins of the SAPAP/GKAP family. Biochem Biophys Res Commun 264:247-252.
7. Bonaglia MC, Giorda R, Borgatti R, Felisari G, Gagliardi C, Selicorni A, Zuffardi O. 2001. Disruption of the ProSAP2 gene in a t(12;22)(q24.1;q13.3) is associated with the 22q13.3 deletion syndrome. Am J Hum Genet 69:261-268.
8. Bonaglia MC, Giorda R, Mani E, Aceti G, Anderlid BM, Baroncini A, Pramparo T, et al. 2006. Identification of a recurrent breakpoint within the SHANK3 gene in the 22q13.3 deletion syndrome. J Med Genet 43:822-828.
9. Bozdagi O, Sakurai T, Papapetrou D, Wang X, Dickstein DL, Takahashi N, Kajiwara Y, et al. 2010. Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication. Mol Autism 1:1-5.
10. Chilian B, Abdollahpour H, Bierhals T, Haltrich I, Fekete G, Nagel I, Rosenberger G, et al. 2013. Dysfunction of SHANK2 and CHRNA7 in a patient with intellectual disability and language impairment supports genetic epistasis of the two loci. Clin Genet. [Epub ahead of print]
11. Critchlow HM, Maycox PR, Skepper JN, Krylova O. 2006. Clozapine and haloperidol differentially regulate dendritic spine formation and synaptogenesis in rat hippocampal neurons. Mol Cell Neurosci 32:356-365.
12. Denayer A, Van Esch H, de Ravel T, Frijns JP, Van Buggenhout G, Vogels A, Devriendt K, et al. 2012. Neuropsychopathology in 7 patients with the 22q13 deletion syndrome: Presence of bipolar disorder and progressive loss of skills. Mol Syndromol 3:14-20.
13. Du Y, Weed SA, Xiong WC, Marshall TD, Parsons JT. 1998. Identification of a novel cortactin SH3 domain-binding protein and its localization to growth cones of cultured neurons. Mol Cell Biol 18:5838-5851.
14. Durand CM, Betancur C, Boeckers TM, Bockmann J, Chaste P, Fauchereau F, Nygren G, et al. 2007. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat Genet 39:25-27.
15. Ey E, Yang M, Katz AM, Woldeyohannes L, Silverman JL, Leblond CS, Faure P, et al. 2012. Absence of deficits in social behaviors and ultrasonic vocalizations in later generations of mice lacking neuroligin4. Genes Brain Behav 11:928-941.
16. Failla P, Romano C, Alberti A, Vasta A, Buono S, Castiglia L, Luciano D, et al. 2007. Schizophrenia in a patient with subtelomeric duplication of chromosome 22q. Clin Genet 71:599-601.
17. Flint J, Wilkie AO, Buckle VJ, Winter RM, Holland AJ, McDermid HE. 1995. The detection of subtelomeric chromosomal rearrangements in idiopathic mental retardation. Nat Genet 9:132-140.
18. Gauthier J, Champagne N, Lafreniere RG, Xiong L, Spiegelman D, Brustein E, Lapointe M, et al. 2010. De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia. Proc Natl Acad Sci USA 107:7863-7868.
19. Gauthier J, Spiegelman D, Piton A, Lafreniere RG, Laurent S, St-Onge J, Lapointe L, et al. 2009. Novel de novo SHANK3 mutation in autistic patients. Am J Med Genet B Neuropsychiatr Genet 150B:421-424.
20. Gong Y, Lippa CF, Zhu J, Lin Q, Rosso AL. 2009. Disruption of glutamate receptors at Shank-postsynaptic platform in Alzheimer's disease. Brain Res 1292:191-198.
21. Grabrucker AM, Schmeisser MJ, Schoen M, Boeckers TM. 2011. Postsynaptic ProSAP/Shank scaffolds in the cross-hair of synaptopathies. Trends Cell Biol 21:594-603.
22. Hardy J, Selkoe DJ. 2002. The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297:353-356.
23. Hung AY, Futai K, Sala C, Valtschanoff JG, Ryu J, Woodworth MA, Kidd FL, et al. 2008. Smaller dendritic spines, weaker synaptic transmission, but enhanced spatial learning in mice lacking Shank1. J Neurosci 28:1697-1708.
24. Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, Pickering-Brown S, et al. 1998. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393:702-705.
25. Jamain S, Quach H, Betancur C, Rastam M, Colineaux C, Gillberg IC, Soderstrom H, et al. 2003. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet 34:27-29.
26. Leblond CS, Heinrich J, Delorme R, Proepper C, Betancur C, Huguet G, Konyukh M, et al. 2012. Genetic and functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders. PLoS Genet 8:e1002521.
27. Lennertz L, Wagner M, Wolwer W, Schuhmacher A, Frommann I, Berning J, Schulze-Rauschenbach S, et al. 2012. A promoter variant of SHANK1 affects auditory working memory in schizophrenia patients and in subjects clinically at risk for psychosis. Eur Arch Psychiatry Clin Neurosci 262:117-124.
28. Lesca G, Rudolf G, Labalme A, Hirsch E, Arzimanoglou A, Genton P, Motte J, et al. 2012. Epileptic encephalopathies of the Landau-Kleffner and continuous spike and waves during slow-wave sleep types: Genomic dissection makes the link with autism. Epilepsia 53:1526-1538.
29. Lim S, Naisbitt S, Yoon J, Hwang JI, Suh PG, Sheng M, Kim E. 1999. Characterization of the Shank family of synaptic proteins. Multiple genes, alternative splicing, and differential expression in brain and development. J Biol Chem 274:29510-29518.
30. Misceo D, Rodningen OK, Baroy T, Sorte H, Mellembakken JR, Stromme P, Fannemel M, et al. 2011. A translocation between Xq21.33 and 22q13.33 causes an intragenic SHANK3 deletion in a woman with Phelan-McDermid syndrome and hypergonadotropic hypogonadism. Am J Med Genet A 155A:403-408.
31. Moessner R, Marshall CR, Sutcliffe JS, Skaug J, Pinto D, Vincent J, Zwaigenbaum L, et al. 2007. Contribution of SHANK3 mutations to autism spectrum disorder. Am J Hum Genet 81:1289-1297.
32. Naisbitt S, Kim E, Tu JC, Xiao B, Sala C, Valtschanoff J, Weinberg RJ, et al. 1999. Shank, a novel family of postsynaptic density proteins that binds to the NMDA receptor/PSD-95/GKAP complex and cortactin. Neuron 23:569-582.
33. Nesslinger NJ, Gorski JL, Kurczynski TW, Shapira SK, Siegel-Bartelt J, Dumanski JP, Cullen RF Jr., et al. 1994. Clinical, cytogenetic, and molecular characterization of seven patients with deletions of chromosome 22q13.3. Am J Hum Genet 54:464-472.
34. Peca J, Feliciano C, Ting JT, Wang W, Wells MF, Venkatraman TN, Lascola CD, et al. 2011. Shank3 mutant mice display autistic-like behaviours and striatal dysfunction. Nature 472:437-442.
35. Pham E, Crews L, Ubhi K, Hansen L, Adame A, Cartier A, Salmon D, et al. 2010. Progressive accumulation of amyloid-beta oligomers in Alzheimer's disease and in amyloid precursor protein transgenic mice is accompanied by selective alterations in synaptic scaffold proteins. FEBS J 277:3051-3067.
36. Phelan K, McDermid HE. 2012. The 22q13.3 deletion syndrome (Phelan-McDermid syndrome). Mol Syndromol 2:186-201.
37. Phelan MC, Rogers RC, Saul RA, Stapleton GA, Sweet K, McDermid H, Shaw SR, et al. 2001. 22q13 deletion syndrome. Am J Med Genet 101:91-99.
38. Pinto D, Pagnamenta AT, Klei L, Anney R, Merico D, Regan R, Conroy J, et al. 2010. Functional impact of global rare copy number variation in autism spectrum disorders. Nature 466:368-372.
39. Quon D, Wang Y, Catalano R, Scardina JM, Murakami K, Cordell B. 1991. Formation of beta-amyloid protein deposits in brains of transgenic mice. Nature 352:239-241.
40. Roselli F, Hutzler P, Wegerich Y, Livrea P, Almeida OF. 2009. Disassembly of shank and homer synaptic clusters is driven by soluble beta-amyloid(1-40) through divergent NMDAR-dependent signalling pathways. PLoS One 4:e6011.
41. Rovelet-Lecrux A, Hannequin D, Guillin O, Legallic S, Jurici S, Wallon D, Frebourg T, et al. 2010. Frontotemporal dementia phenotype associated with MAPT gene duplication. J Alzheimers Dis 21:897-902.
42. Sato D, Lionel AC, Leblond CS, Prasad A, Pinto D, Walker S, O'Connor I, et al. 2012. SHANK1 deletions in males with autism spectrum disorder. Am J Hum Genet 90:879-887.
43. Schluth-Bolard C, Labalme A, Cordier MP, Till M, Nadeau G, Tevissen H, Lesca G, et al. 2013. Breakpoint mapping by next generation sequencing reveals causative gene disruption in patients carrying apparently balanced chromosome rearrangements with intellectual deficiency and/or congenital malformations. J Med Genet 50:144-150.
44. Schmeisser MJ, Ey E, Wegener S, Bockmann J, Stempel AV, Kuebler A, Janssen AL, et al. 2012. Autistic-like behaviours and hyperactivity in mice lacking ProSAP1/Shank2. Nature 486:256-260.
45. Shaw-Smith C, Pittman AM, Willatt L, Martin H, Rickman L, Gribble S, Curley R, et al. 2006. Microdeletion encompassing MAPT at chromosome 17q21.3 is associated with developmental delay and learning disability. Nat Genet 38:1032-1037.
46. Silverman JL, Turner SM, Barkan CL, Tolu SS, Saxena R, Hung AY, Sheng M, et al. 2011. Sociability and motor functions in Shank1 mutant mice. Brain Res 1380:120-137.
47. Sovner R, Stone A, Fox C. 1996. Ring chromosome 22 and mood disorders. J Intellect Disabil Res 40 (Part 1):82-86.
48. Sudhof TC. 2008. Neuroligins and neurexins link synaptic function to cognitive disease. Nature 455:903-911.
49. Toro R, Konyukh M, Delorme R, Leblond C, Chaste P, Fauchereau F, Coleman M, et al. 2010. Key role for gene dosage and synaptic homeostasis in autism spectrum disorders. Trends Genet 26:363-372.
50. Verhoeven WM, Egger JI, Cohen-Snuijf R, Kant SG, de Leeuw N. 2013. Phelan-McDermid syndrome: Clinical report of a 70-year-old woman. Am J Med Genet A 161A:158-161.
51. Verhoeven WM, Egger JI, Willemsen MH, de Leijer GJ, Kleefstra T. 2012. Phelan-McDermid syndrome in two adult brothers: Atypical bipolar disorder as its psychopathological phenotype? Neuropsychiatr Dis Treat 8:175-179.
52. Verpelli C, Schmeisser MJ, Sala C, Boeckers TM. 2012. Scaffold proteins at the postsynaptic density. Adv Exp Med Biol 970:29-61.
53. Vucurovic K, Landais E, Delahaigue C, Eutrope J, Schneider A, Leroy C, Kabbaj H, et al. 2012. Bipolar affective disorder and early dementia onset in a male patient with SHANK3 deletion. Eur J Med Genet 55:625-629.
54. Waga C, Okamoto N, Ondo Y, Fukumura-Kato R, Goto Y, Kohsaka S, Uchino S. 2011. Novel variants of the SHANK3 gene in Japanese autistic patients with severe delayed speech development. Psychiatr Genet 21:208-211.
55. Wang X, McCoy PA, Rodriguiz RM, Pan Y, Je HS, Roberts AC, Kim CJ, et al. 2011. Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3. Hum Mol Genet 20:3093-3108.
56. Watt JL, Olson IA, Johnston AW, Ross HS, Couzin DA, Stephen GS. 1985. A familial pericentric inversion of chromosome 22 with a recombinant subject illustrating a 'pure' partial monosomy syndrome. J Med Genet 22:283-287.
57. Willemsen MH, Rensen JH, van Schrojenstein-Lantman de Valk HM, Hamel BC, Kleefstra T. 2012. Adult phenotypes in Angelman- and Rett-like syndromes. Mol Syndromol 2:217-234.
58. Wilson HL, Crolla JA, Walker D, Artifoni L, Dallapiccola B, Takano T, Vasudevan P, et al. 2008. Interstitial 22q13 deletions: Genes other than SHANK3 have major effects on cognitive and language development. Eur J Hum Genet 16:1301-1310.
59. Wischmeijer A, Magini P, Giorda R, Gnoli M, Ciccone R, Cecconi L, Franzoni E, et al. 2011. Olfactory receptor-related duplicons mediate a microdeletion at 11q13.2q13.4 associated with a syndromic phenotype. Mol Syndromol 1:176-184.
60. Wohr M, Roullet FI, Hung AY, Sheng M, Crawley JN. 2011. Communication impairments in mice lacking Shank1: Reduced levels of ultrasonic vocalizations and scent marking behavior. PLoS One 6:e20631.
61. Won H, Lee HR, Gee HY, Mah W, Kim JI, Lee J, Ha S, et al. 2012. Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function. Nature 486:261-265.
62. Yang M, Bozdagi O, Scattoni ML, Wohr M, Roullet FI, Katz AM, Abrams DN, et al. 2012. Reduced excitatory neurotransmission and mild autism-relevant phenotypes in adolescent Shank3 null mutant mice. J Neurosci 32:6525-6541.